Although our findings provide useful insights into the performance of BE3 and BE3-Y130F at the MYO7A locus, a clinically relevant target for modeling Usher syndrome, it is difficult to draw broad conclusions about their overall efficiency and editing characteristics based on a single genomic site. The gene discussed is MYO7A; the disease is Usher syndrome.